- Home
- CWST vs CNTA Comparison
CWST vs CNTA Comparison
Compare CWST & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CWST | CNTA |
|---|---|---|
| Founded | 1975 | 2020 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Environmental Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 6.1B |
| IPO Year | 1997 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CWST | CNTA |
|---|---|---|
| Price | $86.18 | $40.54 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 9 |
| Target Price | ★ $115.71 | $43.17 |
| AVG Volume (30 Days) | 586.9K | ★ 1.7M |
| Earning Date | 04-30-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 29.13 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,836,841,000.00 | $15,000,000.00 |
| Revenue This Year | $10.95 | N/A |
| Revenue Next Year | $6.97 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 17.95 | N/A |
| 52 Week Low | $74.05 | $12.78 |
| 52 Week High | $117.46 | $40.26 |
Technical Indicators
Market Signals| Indicator | CWST | CNTA |
|---|---|---|
| Relative Strength Index (RSI) | 50.11 | 78.57 |
| Support Level | $83.55 | $39.26 |
| Resistance Level | $90.35 | N/A |
| Average True Range (ATR) | 2.92 | 0.20 |
| MACD | -0.23 | -0.01 |
| Stochastic Oscillator | 40.85 | 99.46 |
Price Performance
Historical ComparisonAbout CWST Casella Waste Systems Inc.
Casella Waste Systems Inc is a solid waste removal company, providing resource management services to residential, commercial, municipal, and industrial customers. The company's reportable segments on Geographical basis include Eastern, Western and Mid-Atlantic regions through the Resource solution segment. It generates maximum revenue from the Western region segment. The company's services include Recycling, Collection, Organics, Energy, Landfills, Special Waste as well as Professional Services.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage biotechnology company pioneering a new class of therapeutics in orexin-based neuroscience. The group is developing a franchise of small molecule orexin receptor 2 (OX2R) agonists designed to address neuroscience diseases underpinned by dysregulation of wakefulness, attention, cognition, mood, and other symptoms, each grounded in the shared biology of the orexin pathway. The company's programs and Pipeline are the Orexin Receptor 2 Agonist Program and LockBody Technology Platform.